Looking ahead, Chattem sees 2006 earnings, before items and stock-based compensation costs, of $2.30 to $2.40 a share. Analysts predict earnings of $2.24 a share, including stock-based compensation costs. Chattem projects full-year sales of $315 million to $330 million, compared with Wall Street's forecast of $328.5 million. Shares were down $4.81 to $36.95.Other health care volume movers included Pfizer (PFE), up 37 cents to $26.74; Johnson & Johnson (JNJ), up 53 cents to $59.13; Schering-Plough (SGP), down 4 cents to $18.63; Boston Scientific (BSX), down 1 cent to $22.22; Genta (GNTA), down 18 cents to $3.16; Amgen (AMGN), down 59 cents to $71.46; Bristol-Myers Squibb (BMY - Get Report), down 10 cents to $22.64; Elan (ELN), up 10 cents to $14.50; and Merck (MRK), up 17 cents to $34.46.
Today's Health Winners and Losers
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.